Immucell Corp (ICCC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2000 | 12-1999 | 12-1998 | 12-1997 | 12-1996 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 2,220 | 550 | -100 | 260 | -60 |
| Depreciation Amortization | 130 | 100 | 100 | N/A | N/A |
| Other Working Capital | -520 | -70 | 500 | N/A | N/A |
| Other Operating Activity | -1,750 | 100 | 140 | -160 | -10 |
| Operating Cash Flow | $80 | $680 | $640 | $100 | $-70 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -270 | -130 | -60 | N/A | N/A |
| Other Investing Activity | -40 | -260 | 20 | -80 | -490 |
| Investing Cash Flow | $-310 | $-390 | $-40 | $-80 | $-490 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 290 | 0 | -80 | -30 | 60 |
| Financing Cash Flow | $290 | $0 | $-80 | $-30 | $60 |
| Beginning Cash Position | 1,820 | 1,530 | 1,020 | 1,040 | 1,550 |
| End Cash Position | 1,890 | 1,820 | 1,530 | 1,020 | 1,040 |
| Net Cash Flow | $70 | $280 | $510 | $-20 | $-500 |
| Free Cash Flow | |||||
| Operating Cash Flow | 80 | 680 | 640 | 100 | -70 |
| Free Cash Flow | 80 | 680 | 640 | 100 | -70 |